StockData
GeoVax Labs, Inc. logo

GeoVax Labs, Inc. (GOVX) stock

GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$2.02+0.31 (+18.48%)

Close on Nov 16, 2026Market cap $14.89MP/E –Yield –

GeoVax Labs total assets

Total assets on the balance sheet at the end of each period.

GeoVax Labs's total assets was $4.64M at Jun 30, 2026. For fiscal 2025 it was $6.34M, down 22.2% from the year before. Over ten years it grew 16.9% a year on average. The highest annual figure on record is $31.35M in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.34M-22.2%
FY2024Dec 31, 2024$8.16M-12.1%
FY2023Dec 31, 2023$9.28M-70.4%
FY2022Dec 31, 2022$31.35M+165.7%
FY2021Dec 31, 2021$11.80M+13.5%
FY2020Dec 31, 2020$10.39M+2116.8%
FY2019Dec 31, 2019$468.88K-27.0%
FY2018Dec 31, 2018$642.06K+31.0%
FY2017Dec 31, 2017$490.24K-19.7%
FY2016Dec 31, 2016$610.22K-54.2%
FY2015Dec 31, 2015$1.33M-0.1%
FY2014Dec 31, 2014$1.33M-53.0%
FY2013Dec 31, 2013$2.84M+92.1%
FY2012Dec 31, 2012$1.48M-10.2%
FY2011Dec 31, 2011$1.65M-30.2%
FY2010Dec 31, 2010$2.36M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.64M-13.2%
Q1 FY2026Mar 31, 2026$2.98M-72.5%
Q4 FY2025Dec 31, 2025$6.34M-22.2%
Q3 FY2025Sep 30, 2025$6.73M-39.4%
Q2 FY2025Jun 30, 2025$5.35M+30.7%
Q1 FY2025Mar 31, 2025$10.83M+222.6%
Q4 FY2024Dec 31, 2024$8.16M-12.1%
Q3 FY2024Sep 30, 2024$11.11M-31.4%
Q2 FY2024Jun 30, 2024$4.10M-80.7%
Q1 FY2024Mar 31, 2024$3.36M-87.7%
Q4 FY2023Dec 31, 2023$9.28M-70.4%
Q3 FY2023Sep 30, 2023$16.20M-58.0%
Q2 FY2023Jun 30, 2023$21.25M-36.1%
Q1 FY2023Mar 31, 2023$27.40M+62.6%
Q4 FY2022Dec 31, 2022$31.35M+165.7%
Q3 FY2022Sep 30, 2022$38.57M+110.3%
Q2 FY2022Jun 30, 2022$33.24M+67.7%
Q1 FY2022Mar 31, 2022$16.85M-20.2%
Q4 FY2021Dec 31, 2021$11.80M+13.5%
Q3 FY2021Sep 30, 2021$18.34M+56.0%
Q2 FY2021Jun 30, 2021$19.82M+1968.7%
Q1 FY2021Mar 31, 2021$21.12M+2441.5%
Q4 FY2020Dec 31, 2020$10.39M+2116.8%
Q3 FY2020Sep 30, 2020$11.76M+1339.7%
Q2 FY2020Jun 30, 2020$957.94K+179.6%
Q1 FY2020Mar 31, 2020$830.83K+75.8%
Q4 FY2019Dec 31, 2019$468.88K-27.0%
Q3 FY2019Sep 30, 2019$816.53K+31.0%
Q2 FY2019Jun 30, 2019$342.63K-7.7%
Q1 FY2019Mar 31, 2019$472.64K-43.7%
Q4 FY2018Dec 31, 2018$642.06K+31.0%
Q3 FY2018Sep 30, 2018$623.47K+25.8%
Q2 FY2018Jun 30, 2018$371.38K-62.5%
Q1 FY2018Mar 31, 2018$839.51K+176.4%
Q4 FY2017Dec 31, 2017$490.24K-19.7%
Q3 FY2017Sep 30, 2017$495.64K-26.6%
Q2 FY2017Jun 30, 2017$990.01K–
Q1 FY2017Mar 31, 2017$303.68K–
Q4 FY2016Dec 31, 2016$610.22K–
Q3 FY2016Sep 30, 2016$675.19K–

More GeoVax Labs figures

See a number that looks wrong?